FOR PHARMACISTS · SCIENTIFIC COLLECTION 10.0310 monographs · 36 SOPs · 22 forms

CGR-FR-012 / EDITION 10.0

Zinc oxide starch glycerolate Ph. Fr.

Paste · France

2026-10-14Reference monograph · Local adoption

REFERENCE FORMULA

Reference formula

Reference basis: 100 g

IngredientSource quantityScaled quantity
Zinc oxide33 g—
Starch glycerolate Ph. Fr.67 g—

REFERENCE FORMULA SCALING

Proportional quantities of the same formula

Arithmetic aid. It does not change strength, dose, method or BUD and does not authorise compounding.

Scaling

Prerequisite formulations

Documentation

Preparation description
Homogeneous white to nearly white semi-solid gel. [1]
Action and use
Topical emollient and skin protectant according to the monograph. [1]
Specifications
ZnO: 29.7–36.3% w/w [1]
Light
Finished-product photostability is not specified. Any required container light protection is stated under Storage. [1]
Air and oxidation
No oxidative stability study of the finished mixture or inert-atmosphere requirement is provided. Use the source container. [1]
Water and solubility
ZnO: practically insoluble in water and ethanol.
Component of base CGR-FR-011: Glycerol is miscible with water. This does not establish product microbiological stability. [2], [6], [7]
Humidity
Component of base CGR-FR-011: Glycerol is hygroscopic; limit raw-material exposure to moisture. [6], [7]
Temperature
No permitted temperature excursion or freeze–thaw cycle is established. Processing and storage temperatures are stated in their respective fields. [1]
pH and compatibility
ZnO dissolves in dilute mineral acids and forms soaps with fatty acids. [2]
Other interactions
Component of base CGR-FR-011: Glycerol: hazardous reaction with strong oxidising agents. [6], [7]
Ingredient-specific information
Zinc oxide: light, white to slightly yellowish, amorphous powder without aggregates. Dilute mineral acids dissolve it; fatty acids in a base can form zinc salts.
Component of base CGR-FR-011: Glycerol: clear, colourless, viscous and strongly hygroscopic liquid. It mixes with water but is practically insoluble in fixed and essential oils. [2], [6], [7]
Staff protection
Clean long-sleeved laboratory clothing, hair covering and gloves during handling; change gloves after contamination or damage.
Contain powder during weighing and trituration and use eye protection; select respiratory protection for the actual exposure. [1], [3], [4]
Risk assessment
Reference batch: 100 g. First ingredient: Zinc oxide, 33 g. Independently check chemical form, units and every scale conversion before weighing.
Check homogeneity, aggregates, separation and actual yield before subdivision. Packaging should allow uniform application without introducing water into the contents.
For the local assessment record quantity per preparation, work frequency, duration of open handling, potential exposure routes and effectiveness of controls. These are assessment inputs; no fictitious final risk score is assigned.
Release checkpoint: inspect aggregates, crystals, local texture differences and free liquid after completing the method. Record mixing geometry, batch size and actual temperatures; copying rpm to another mixer does not establish process equivalence. [1], [10], [12]
Compounding conditions
Before mixing: verify each ingredient’s chemical form and lot, record theoretical amounts and check equipment cleanliness. Follow the temperatures and addition sequence in the procedure below. [1], [4]
BUD rationale
No specific experimental period was located covering the complete exact formulation, container and microbiological suitability.
The glycerolate base contains 86.8% glycerol, 6.6% starch and 6.6% water by mass. The binary-mixture study reports aw about 0.34 at initial glycerol volume fraction 0.85. This supports a low-aw working category only with pharmacopoeial glycerol approximately 98% or higher, the exact heating process and no additional water. It is not a finished-paste measurement or a 180-day study; verify the suitability of this representative estimate in the quality system.
Selected general rule: up to 180 days at 20–25 °C for a solid or nonaqueous nonoral-liquid form with supported aw <0.6. Initial quality/moisture, exclusion of water ingress and physical suitability must support this category.
Use-by date = the earliest allowed date from preparation plus selected period, ingredient expiries and any shorter supported limit. In-use dating never extends overall BUD. Complete the actual date for the batch after the required checks.
A default is a conservative dating limit, not experimental proof of batch stability. Its category depends on final composition, preservation and permitted temperatures. Water percentage or loss on drying does not determine aw. Document using SOP-014/F-006; use SOP-017/F-012 for specific aw evidence.
USP clarification: aw measurement is not required for every nonsterile preparation. Category assignment may use the exact composition and relevant representative examples; an uncertain or borderline formulation is best assessed by a suitable specific measurement. This edition contains no measured aw or released batch. The final preparation generally must not outlast the remaining BUD of its compounded bases/intermediates. An exception requires specific justification that physical, chemical and microbiological quality is not adversely affected. Record the final limit, intermediate preparation dates and their actual expiry dates separately. [1], [8], [9], [11], [13]
Prerequisites
Starch glycerolate Ph. Fr.: CGR-FR-011 [1]
Equipment
Balance with suitable minimum weight, mortar/pestle or homogeniser, mixing vessels, spatulas, thermometer for heated processes and volumetric equipment for mL quantities. [1]
Compounding method
Sieve ZnO at 250 µm. Coat the mortar with one third of the base; successively incorporate ZnO and remaining base. [1]
Observations
The final quantity is the master-formula basis. Record actual yield, losses and deviations in the batch record. [1]
Container and packaging
Tube or airtight jar. [1]
Quality control
ZnO: 0.200 g in 10 mL dilute HCl and 20 mL water, then 170 mL water. Complexometry Ph. Eur. 2.5.11; 1 mL 0.1 M EDTA equals 8.14 mg ZnO. Check about 0.2 g for homogeneity, with no visible white aggregates.
Record the method, acceptance criterion, actual result and reviewer separately in F-005. A critical specification failure requires quarantine and investigation under SOP-015; retesting needs justification. [1], [12]
Storage
Tube or airtight jar.
For a general-rule duration, also apply the temperature of the selected BUD category. The source does not support arbitrary temperature changes. [1], [5]
Dispensing
Dispense with a clear route, strength and use-by date. Complete amount per application and frequency from the prescription. [1]
Labelling
Zinc oxide starch glycerolate Ph. Fr.
External use
Quantity: ____ Batch: ____
Prepared: ____ Use by: ____
Patient / dose / frequency: ____
Storage: Tube or airtight jar.
Temperature for this batch BUD: ____ [1]
v9_controls
The numeric value is a literature reference ceiling subject to its specific conditions. No actual batch BUD has been assigned and no aw measurements have been produced. The exact formula, prerequisites, container, storage and quality evidence require approval for the actual application. The BUD clock starts when compounding begins. Use the shortest applicable supported limit and assess in-use dating separately. USP categories are a technical framework and are not presented as Greek legislation.

Independent Greek/English adaptation and organisation of facts from the cited source. This is not an official translation or publisher endorsement.

Sources and references

  1. Glycérolé à l'oxyde de zinc (2007) (15/02/2012)2007PDF pp. 1–2master formula2026-10-14
  2. FN/2003/PA/028 ÓXIDO DE ZINCΔιαθέσιμο κείμενο / Retrieved textPDF pp. 1–2raw material or occupational2026-09-10
  3. PN/L/PG/002/00 INDUMENTARIAΔιαθέσιμο κείμενο / Retrieved textPDF pp. 1–5general staff protection2026-09-10
  4. ASHP — USP <795> Key Changes2023pp. 1–3: scope, water activity and staff precautionsprofessional guidance; not the licensed USP chapter2026-09-12
  5. Texas State Board of Pharmacy — adopted 22 TAC §291.131, nonsterile compoundingTexas Register, 7 June 2024Beyond-use dating: aw categories, 14/35/90/180 days, limits and extensionspublic regulatory implementation of USP <795> BUD framework; not Greek law2026-09-12
  6. FN/2003/PA/013 GLICEROLRetrieved source editionSections 4, 6–10ingredient facts2026-09-12
  7. Glycérolé d'amidon (2007) (15/02/2012)2007PDF pp. 1–2master formula2026-09-10
  8. Illinois IDFPR — Nonsterile Compounding Self-Inspection ReportPublic checklist, retrieved 12 September 2026pp. 15–16, Establishing beyond-use datesPublic regulatory implementation of USP <795>; not Greek law; general limits and requirements for extension2026-09-12
  9. Nakagawa T, Oyama T. Molecular Basis of Water Activity in Glycerol–Water MixturesFrontiers in Chemistry. 2019;7:731Table 1; DOI 10.3389/fchem.2019.00731Full text read. Glycerol/water experimental system; not a stability study of suppositories or starch glycerolate2026-09-12
  10. NIOSH — Managing Hazardous Drug Exposures: Information for Healthcare Settings2023; DHHS (NIOSH) 2023-130Risk assessment; printed pp. 27–33, activity/formulation control tableWorkplace exposure, hierarchy of controls and activity-specific PPE; US government public-domain document2026-09-12
  11. USP — Compounding Standards and Beyond-Use Dates, 2022 updateNovember 2022, published by USP; public copy hosted by Mississippi Boardpp. 1–2; nonsterile tableRisk-based default categories; not product-specific stability or Greek law2026-09-12
  12. PIC/S — Guide to Good Practices for the Preparation of Medicinal Products in Healthcare EstablishmentsPE 010-4, 1 March 2014Chapters 1–9; Annex 2 (nonsterile liquids, creams, ointments)Professional quality-system framework; not automatic national legal adoption or certification2026-09-12
  13. USP — General Chapter <795> FAQsUpdated 1 November 2023Questions 52, 54–56, 60–62; PDF pp. 11–14Primary clarification of aw classification, extension prerequisites and compounded-component BUDs; not automatic Greek legal adoption2026-10-14